Desktop Genetics Receives Strategic Investment from Illumina

Loading...
Loading...
Desktop Genetics Ltd announced today that it has received investment funding from Illumina, Inc.
ILMN
, the global leader in next-generation sequencing (NGS) technology. The investment will be used to fund the continued development and commercialization of the DESKGEN platform with a particular focus on integration with NGS pipelines. The investment from Illumina follows DTG's recent fundraising from a syndicate of venture capitalists and angel investors. This combined funding is being used to continue developing DTG's proprietary DESKGEN genome editing software platform and core CRISPR algorithms. DTG is also investing in the expansion of its existing sales
See full press release
Posted In: NewsPress Releases
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...